Refining Treatment Approaches for Chronic Lymphocytic Leukemia - Episode 15
CLL: Venetoclax in the R/R Setting
William Wierda, MD, PhD, University of Texas MD Anderson Cancer Center, John Allan, MD, Weill Cornell Medicine, Ehab Atallah, MD, Medical College of Wisconsin, Steven Coutre, MD, Stanford University Medical Center, Nicole Lamanna, MD, Herbert Irving Comprehensive Cancer Center, Jennifer Woyach, MD, Ohio State University
Experts in chronic lymphocytic leukemia (CLL) discuss retreating patients with venetoclax.
Related Content:
